Therefore, we used the TCGA, CPTAC, HPA, and GEPIA2 databases or websites to conduct pancancer analysis of RIPK2, and explore the molecular mechanism and clinical prognosis of RIPK2 in cancer. The gene discussed is RIPK2; the disease is cancer.